Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immunoglobulin E receptor (IgE Receptor) refers to cell-surface proteins that specifically bind to the constant region of Immunoglobulin E (IgE) antibodies. These receptors are central to the allergic response and play a key role in immune defense against parasites. The high-affinity receptor (FcεRI) triggers degranulation and release of mediators upon allergen exposure, while the low-affinity receptor (CD23/FcεRII) regulates serum IgE levels and facilitates allergen presentation.
Monoclonal antibodies that bind free human IgE, preventing interaction with FcεRI/CD23.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin E Receptor (IgE Receptor).